Han Han

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R. S. K. Vijayan et al. · Cancer Cell · 2019 · 241 citations · Full text

Medicine, Oncology, Pharmacology +14

CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer

Hua Zhang, Camilla L. Christensen, Ruben Dries et al. · Cancer Cell · 2019 · 224 citations · Full text

Medicine, Cancer Biology, Oncology +12

ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer

Jiehui Deng, Aatish Thennavan, Igor Dolgalev et al. · Nature Cancer · 2021 · 140 citations · Full text

Medicine, Cancer Biology, Oncology +13

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

Yuanwang Pan, Han Han, Hai Hu et al. · Cancer Cell · 2022 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +17

MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression

Wu ., De-gang, Wang et al. · 中华医学杂志：英文版 · 2011 · 97 citations

Life Sciences, Molecular Biology, Oncology +16